EMA Authorised: Cetrotide (cetrorelix (as acetate)) — Merck Europe B.V.

View source ↗

Summary

The European Medicines Agency authorised Cetrotide (cetrorelix acetate) for ovulation induction, with Merck Europe B.V. as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Ovulation Disorders

Drugs mentioned

• CETROTIDE (cetrorelix acetate)

Snippet

Status: Authorised. Therapeutic area: Ovulation;Ovulation Induction. MAH: Merck Europe B.V.. Decision date: 27/01/2026